OncoSec Medical Incorporated (ONCS) Stock Balance Sheet
NASDAQ:ONCS - Nasdaq - US68234L4059 - Common Stock - Currency: USD
| MRQ (2023-1-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | 2020 (2020-7-31) | 2019 (2019-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 3.68M | 12.30M | 45.95M | 20.35M | 25.15M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 2.76M | 2.93M | 3.23M | 2.47M | 3.36M | |||
| Total Current Assets | 6.44M | 15.23M | 49.18M | 22.82M | 28.51M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.52M | 5.64M | 6.37M | 6.76M | 1.03M | |||
| Intangibles | 343.59K | 378.53K | 448.41K | N/A | N/A | |||
| Other Non-Current Assets | 562.31K | 623.24K | 273.52K | 320.00K | 350.00K | |||
| Total Non-Current Assets | 2.43M | 6.65M | 7.10M | 7.08M | 1.38M | |||
| TOTAL ASSETS | 8.87M | 21.88M | 56.28M | 29.90M | 29.89M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 80.00K | |||
| Current Portion Of LT Debt. | 379.54K | 936.56K | 1.23M | 970.00K | N/A | |||
| Accrued Expenses | 6.58M | 5.58M | 6.60M | 8.61M | 4.26M | |||
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Liabilities | 268.89K | 120.18K | 125.68K | 90.00K | 630.00K | |||
| Total Current Liabilities | 7.23M | 6.63M | 7.96M | 9.68M | 4.98M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.91M | 0.00 | 0.00 | 480.00K | 0.00 | |||
| Other Non-Current Liabilities | 5.21M | 9.13M | 10.24M | 5.87M | 640.00K | |||
| Total Non-Current Liabilities | 7.13M | 9.13M | 10.24M | 6.35M | 630.00K | |||
| TOTAL LIABILITIES | 14.36M | 15.76M | 18.20M | 16.03M | 5.61M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -300.88M | -282.37M | -248.19M | -200.90M | -153.55M | |||
| Additional Paid In Capital | 295.24M | 288.23M | 286.34M | 214.79M | 177.66M | |||
| Common Shares | 300.00 | 3.94K | 3.92K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 153.68K | 247.21K | -79.11K | -20.00K | 170.00K | |||
| Shares Outstanding | 2.97M | 1.79M | 1.78M | 23.05M | 10.63M | |||
| Tangible Book Value per Share | -1.96 | 3.21 | 21.14 | 0.60 | 2.28 | |||
| Total Shareholders' Equity | -5.49M | 6.12M | 38.08M | 13.87M | 24.28M | |||
| TOTAL LIABILITIES AND EQUITY | 8.87M | 21.88M | 56.28M | 29.90M | 29.89M | |||
| Statistics | ||||||||
| Debt/Equity | -0.35 | N/A | N/A | 0.03 | N/A | |||
| Current Ratio | 0.89 | 2.30 | 6.18 | 2.36 | 5.72 | |||
| Return On Assets (ROA) | -331.25% | -156.23% | -80.26% | -141.30% | -101.30% | |||
| Return On Equity (ROE) | N/A | -558.64% | -118.63% | -304.61% | -124.71% | |||
All data in USD , ROIC based on taxRate of 0.21